PT2857404T - Derivados de imidazo[1,2-b]piridazina como inibidores da cinase - Google Patents

Derivados de imidazo[1,2-b]piridazina como inibidores da cinase

Info

Publication number
PT2857404T
PT2857404T PT138013206T PT13801320T PT2857404T PT 2857404 T PT2857404 T PT 2857404T PT 138013206 T PT138013206 T PT 138013206T PT 13801320 T PT13801320 T PT 13801320T PT 2857404 T PT2857404 T PT 2857404T
Authority
PT
Portugal
Prior art keywords
imidazo
kinase inhibitors
pyridazine derivatives
pyridazine
derivatives
Prior art date
Application number
PT138013206T
Other languages
English (en)
Inventor
Tominaga Yuichi
Takeda Yasuyuki
Yoshikawa Kenji
Kagoshima Yoshiko
Yamamoto Yuko
Tanaka Ryoichi
Kiga Masaki
Hamada Yoshito
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of PT2857404T publication Critical patent/PT2857404T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
PT138013206T 2012-06-04 2013-06-03 Derivados de imidazo[1,2-b]piridazina como inibidores da cinase PT2857404T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012127079 2012-06-04

Publications (1)

Publication Number Publication Date
PT2857404T true PT2857404T (pt) 2017-11-23

Family

ID=49711970

Family Applications (1)

Application Number Title Priority Date Filing Date
PT138013206T PT2857404T (pt) 2012-06-04 2013-06-03 Derivados de imidazo[1,2-b]piridazina como inibidores da cinase

Country Status (32)

Country Link
US (2) US9187489B2 (pt)
EP (1) EP2857404B1 (pt)
JP (1) JP5814467B2 (pt)
KR (1) KR101781255B1 (pt)
CN (1) CN104520300B (pt)
AU (1) AU2013272701B2 (pt)
BR (1) BR112014029851B1 (pt)
CA (1) CA2874819C (pt)
CO (1) CO7160119A2 (pt)
CY (1) CY1119607T1 (pt)
DK (1) DK2857404T3 (pt)
ES (1) ES2648228T3 (pt)
HK (1) HK1207374A1 (pt)
HR (1) HRP20171724T1 (pt)
HU (1) HUE037221T2 (pt)
IL (1) IL236075A (pt)
IN (1) IN2014MN02497A (pt)
LT (1) LT2857404T (pt)
MX (1) MX357021B (pt)
MY (1) MY170326A (pt)
NO (1) NO2857404T3 (pt)
NZ (1) NZ702574A (pt)
PH (1) PH12014502721B1 (pt)
PL (1) PL2857404T3 (pt)
PT (1) PT2857404T (pt)
RS (1) RS56625B1 (pt)
RU (1) RU2635917C2 (pt)
SG (1) SG11201408052WA (pt)
SI (1) SI2857404T1 (pt)
TW (1) TWI585088B (pt)
WO (1) WO2013183578A1 (pt)
ZA (1) ZA201408843B (pt)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2350075E (pt) 2008-09-22 2014-06-09 Array Biopharma Inc Compostos imidazo[1,2b]piridazina substituídos como inibidores da trk cinase
SG10201914059WA (en) 2008-10-22 2020-03-30 Array Biopharma Inc Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
AR077468A1 (es) 2009-07-09 2011-08-31 Array Biopharma Inc Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
MX365251B (es) 2010-05-20 2019-05-28 Array Biopharma Inc Compuestos macrocíclicos como inhibidores de trk cinasa.
KR20150015501A (ko) 2012-05-30 2015-02-10 니뽄 신야쿠 가부시키가이샤 방향족 복소환 유도체 및 의약
BR112016021507B1 (pt) * 2014-03-27 2022-10-18 Janssen Pharmaceutica Nv Derivados de 4,5,6,7-tetra-hidro-pirazolo[1,5-a]pirimidina substituídos e derivados de 2,3-dihidro-1himidazo[1,2-b]pirazol como inibidores do ros1 e composição farmacêutica que os compreende
CA2940918C (en) * 2014-03-27 2023-10-24 Janssen Pharmaceutica Nv Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-.alpha.]pyrazine derivatives and 5,6,7,8-tetrahydro-4h-pyrazolo[1,5-.alpha.][1,4]diazepine derivatives as ros1 inhibitors
ES2874875T3 (es) * 2014-04-25 2021-11-05 Exelixis Inc Procedimiento de tratamiento de adenocarcinoma de pulmón
CN113354649A (zh) 2014-11-16 2021-09-07 阵列生物制药公司 一种新的晶型
MA44936A1 (fr) 2015-06-01 2021-09-30 Loxo Oncology Inc Méthodes de diagnostic et de traitement du cancer
PE20180572A1 (es) 2015-06-18 2018-04-04 Cephalon Inc Derivados de piperidina 1,4-sustituidos
ES2849951T3 (es) 2015-06-18 2021-08-24 89Bio Ltd Derivados de piperidina 4-bencil y 4-benzoil sustituidos
PL3322706T3 (pl) 2015-07-16 2021-07-19 Array Biopharma, Inc. Podstawione związki pirazolo[1,5-a]pirydynowe jako inhibitory kinazy ret
CA3003153A1 (en) 2015-10-26 2017-05-04 Loxo Oncology, Inc. Point mutations in trk inhibitor-resistant cancer and methods relating to the same
CN106854174A (zh) * 2015-12-08 2017-06-16 湖南华腾制药有限公司 一种4位取代哌啶衍生物的制备方法
KR20210010652A (ko) 2016-04-04 2021-01-27 록쏘 온콜로지, 인코포레이티드 소아암을 치료하는 방법
PE20181888A1 (es) 2016-04-04 2018-12-11 Loxo Oncology Inc Formulaciones liquidas de (s)-n-(5-((r)-2-(2,5-difluorofenil)-pirrolidin-1-il)-pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidina-1-carboxamida
US10045991B2 (en) 2016-04-04 2018-08-14 Loxo Oncology, Inc. Methods of treating pediatric cancers
RU2745953C2 (ru) 2016-05-18 2021-04-05 Локсо Онколоджи, Инк. Способ получения (s)-n-(5-((r)-2-(2,5-дифторфенил)пирролидин-1-ил)-пиразоло[1,5-a]пиримидин-3-ил)-3-гидроксипирролидин-1-карбоксамида и его солей
CN107400082A (zh) * 2016-05-19 2017-11-28 湖南华腾制药有限公司 一种取代哌啶衍生物的制备方法
JOP20190077A1 (ar) 2016-10-10 2019-04-09 Array Biopharma Inc مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret
TWI704148B (zh) 2016-10-10 2020-09-11 美商亞雷生物製藥股份有限公司 作為ｒｅｔ激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
JOP20190072A1 (ar) * 2016-10-13 2019-04-07 Glaxosmithkline Ip Dev Ltd مشتقات 1، 3 سيكلوبوتان ثنائي الاستبدال أو آزيتيدين كمثبطات للإنزيم المخلق للبروستاجلاندين d المكون للدم
JOP20190092A1 (ar) 2016-10-26 2019-04-25 Array Biopharma Inc عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
WO2018136661A1 (en) 2017-01-18 2018-07-26 Andrews Steven W SUBSTITUTED PYRAZOLO[1,5-a]PYRAZINE COMPOUNDS AS RET KINASE INHIBITORS
WO2018136663A1 (en) 2017-01-18 2018-07-26 Array Biopharma, Inc. Ret inhibitors
RS64354B1 (sr) * 2017-03-14 2023-08-31 Daiichi Sankyo Co Ltd Postupak za proizvodnju derivata 3, 6-disupstituisanog imidazo[1, 2-b]piridazina
JOP20190213A1 (ar) 2017-03-16 2019-09-16 Array Biopharma Inc مركبات حلقية ضخمة كمثبطات لكيناز ros1
US10180422B1 (en) 2017-08-22 2019-01-15 Scripps Health Methods of treating a neuroendocrine tumor
TWI812649B (zh) 2017-10-10 2023-08-21 美商絡速藥業公司 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物
TWI791053B (zh) 2017-10-10 2023-02-01 美商亞雷生物製藥股份有限公司 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物
US20190247398A1 (en) 2017-10-26 2019-08-15 Array Biopharma Inc. Formulations of a macrocyclic trk kinase inhibitor
CN109748902B (zh) * 2017-11-02 2020-11-06 杭州科巢生物科技有限公司 一种盐酸安罗替尼的制备方法
KR102078775B1 (ko) * 2017-11-29 2020-02-19 서울대학교산학협력단 항-ros1 항체 및 그의 용도
CN108129288B (zh) * 2017-12-27 2021-01-22 上海毕得医药科技股份有限公司 一种反式-3-羟基环丁基甲酸的合成方法
TW201932464A (zh) 2018-01-18 2019-08-16 美商亞雷生物製藥股份有限公司 作為ret激酶抑制劑之經取代吡唑基[4,3-c]吡啶化合物
TWI802635B (zh) 2018-01-18 2023-05-21 美商亞雷生物製藥股份有限公司 作為ｒｅｔ激酶抑制劑之經取代吡咯并[2,3-d]嘧啶化合物
US11524963B2 (en) 2018-01-18 2022-12-13 Array Biopharma Inc. Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors
US20210023086A1 (en) 2018-03-29 2021-01-28 Loxo Oncology, Inc. Treatment of trk-associated cancers
KR102653681B1 (ko) 2018-07-31 2024-04-03 록쏘 온콜로지, 인코포레이티드 (s)-5-아미노-3-(4-((5-플루오로-2-메톡시벤즈아미도)메틸)페닐)-1-(1,1,1-트리플루오로프로판-2-일)-1h-피라졸-4-카르복스아미드의분무-건조된 분산물 및 제제
ES2922314T3 (es) 2018-09-10 2022-09-13 Array Biopharma Inc Compuestos heterocíclicos condensados como inhibidores de cinasa RET
CN113490666A (zh) 2018-12-19 2021-10-08 奥瑞生物药品公司 作为fgfr酪氨酸激酶的抑制剂的取代的吡唑并[1,5-a]吡啶化合物
EP3898615A1 (en) 2018-12-19 2021-10-27 Array Biopharma, Inc. 7-((3,5-dimethoxyphenyl)amino)quinoxaline derivatives as fgfr inhibitors for treating cancer
EP3936192A4 (en) * 2019-03-06 2022-11-16 Daiichi Sankyo Company, Limited PYRROLOPYRAZOL DERIVATIVES
AU2020242287A1 (en) 2019-03-21 2021-09-02 INSERM (Institut National de la Santé et de la Recherche Médicale) A Dbait molecule in combination with kinase inhibitor for the treatment of cancer
WO2020224626A1 (zh) * 2019-05-08 2020-11-12 浙江同源康医药股份有限公司 用作激酶抑制剂的化合物及其应用
US20220401436A1 (en) 2019-11-08 2022-12-22 INSERM (Institute National de la Santé et de la Recherche Médicale) Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
TW202200589A (zh) * 2020-05-28 2022-01-01 瑞士商諾華公司 Ｍｌｌ１抑制劑及抗癌劑
CN114957259A (zh) * 2021-02-25 2022-08-30 南京明德新药研发有限公司 氰基取代的芳香双环类化合物及其应用
CA3223035A1 (en) * 2021-07-01 2023-01-05 Anheart Therapeutics (Hangzhou) Co., Ltd. Crystalline forms of 3-{4-[(2r)-2-aminopropoxy]phenyl}-n-[(1r)- 1-(3-fluorophenyl) ethyl]imidazo[1,2-b]pyridazin-6-amine and salts thereof
WO2023220967A1 (en) * 2022-05-18 2023-11-23 Anheart Therapeutics (Hangzhou) Co., Ltd. Method for producing 3,6-disubstituted-imidazo[1,2-b]pyridazine compounds
CN114989176A (zh) * 2022-07-08 2022-09-02 深圳市新樾生物科技有限公司 咪唑并哒嗪类衍生物及其应用
CN115197115A (zh) * 2022-08-25 2022-10-18 成都金博汇康医药科技有限公司 一种手性5-氧代吡咯烷-3-甲酸的制备方法与应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399780B1 (en) 1999-08-20 2002-06-04 Cephalon, Inc. Isomeric fused pyrrolocarbazoles and isoindolones
WO2002020513A1 (en) 2000-09-01 2002-03-14 Glaxo Group Limited Oxindole derivatives
WO2002020479A1 (en) 2000-09-01 2002-03-14 Glaxo Group Limited Substituted oxindole derivatives as tyrosine kinase inhibitors
JP2003231687A (ja) 2002-02-04 2003-08-19 Japan Tobacco Inc ピラゾリル縮合環化合物及びその医薬用途
MY141220A (en) 2003-11-17 2010-03-31 Astrazeneca Ab Pyrazole derivatives as inhibitors of receptor tyrosine kinases
US20090227648A1 (en) 2004-04-21 2009-09-10 Astrazeneca Ab Pyrazole derivatives useful for the treatment of cancer
US20080167314A1 (en) * 2004-12-28 2008-07-10 Osamu Uchikawa Condensed Imidazole Compound And Use Thereof
RS52061B (en) 2005-02-04 2012-04-30 Astrazeneca Ab PIRAZOLYL-AMINOPYRIDINE DERIVATIVES USEFUL AS KINASE INHIBITORS
WO2006087530A1 (en) 2005-02-16 2006-08-24 Astrazeneca Ab Chemical compounds
ES2347172T3 (es) 2005-02-16 2010-10-26 Astrazeneca Ab Compuestos quimicos.
WO2007013673A1 (en) 2005-07-29 2007-02-01 Astellas Pharma Inc. Fused heterocycles as lck inhibitors
CN101208339B (zh) * 2005-08-01 2010-12-29 霍夫曼-拉罗奇有限公司 杂环苄基氨基衍生物，它们的制备以及作为药剂的应用
DE102005042742A1 (de) 2005-09-02 2007-03-08 Schering Ag Substituierte Imidazo[1,2b]pyridazine als Kinase-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
DE102006029447A1 (de) * 2006-06-21 2007-12-27 Bayer Schering Pharma Ag Oxo-substituierte Imidazo[1,2b]pyridazine, deren Herstellung und Verwendung als Arzneimittel
JP2010508315A (ja) * 2006-10-30 2010-03-18 ノバルティス アーゲー 抗炎症剤としてのヘテロ環式化合物
NZ576234A (en) * 2006-11-06 2011-06-30 Supergen Inc Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
WO2008072682A1 (ja) * 2006-12-15 2008-06-19 Daiichi Sankyo Company, Limited イミダゾ［１，２－ｂ］ピリダジン誘導体
JP2009227599A (ja) * 2008-03-21 2009-10-08 Daiichi Sankyo Co Ltd イミダゾピリダジン誘導体
WO2009140128A2 (en) 2008-05-13 2009-11-19 Irm Llc Compounds and compositions as kinase inhibitors
PT2350075E (pt) * 2008-09-22 2014-06-09 Array Biopharma Inc Compostos imidazo[1,2b]piridazina substituídos como inibidores da trk cinase
KR101147550B1 (ko) * 2009-10-22 2012-05-17 한국과학기술연구원 단백질 키나아제 저해활성을 가지는 2,7-치환된 티에노［3,2-ｄ］피리미딘 화합물
WO2012005299A1 (ja) 2010-07-07 2012-01-12 日本新薬株式会社 Ｒｏｓチロシンキナーゼ阻害剤
WO2012125667A1 (en) 2011-03-17 2012-09-20 Merck Sharp & Dohme Corp. TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF

Also Published As

Publication number Publication date
IL236075A0 (en) 2015-02-01
US9187489B2 (en) 2015-11-17
CO7160119A2 (es) 2015-01-15
MX357021B (es) 2018-06-25
CA2874819C (en) 2017-06-20
EP2857404A4 (en) 2016-01-20
US20160046639A1 (en) 2016-02-18
NZ702574A (en) 2016-07-29
CN104520300A (zh) 2015-04-15
RS56625B1 (sr) 2018-03-30
MY170326A (en) 2019-07-17
IL236075A (en) 2017-10-31
AU2013272701A1 (en) 2015-01-15
EP2857404B1 (en) 2017-08-23
SI2857404T1 (sl) 2017-11-30
PL2857404T3 (pl) 2018-04-30
EP2857404A1 (en) 2015-04-08
DK2857404T3 (en) 2017-12-04
LT2857404T (lt) 2017-11-10
US20150051190A1 (en) 2015-02-19
IN2014MN02497A (pt) 2015-07-17
AU2013272701B2 (en) 2017-12-21
PH12014502721A1 (en) 2015-02-02
RU2635917C2 (ru) 2017-11-17
TWI585088B (zh) 2017-06-01
HUE037221T2 (hu) 2018-08-28
ZA201408843B (en) 2016-01-27
US9751887B2 (en) 2017-09-05
TW201400486A (zh) 2014-01-01
BR112014029851B1 (pt) 2023-01-03
CN104520300B (zh) 2016-12-21
NO2857404T3 (pt) 2018-01-20
KR20150014942A (ko) 2015-02-09
CY1119607T1 (el) 2018-04-04
WO2013183578A1 (ja) 2013-12-12
JPWO2013183578A1 (ja) 2016-01-28
AU2013272701A2 (en) 2015-01-22
SG11201408052WA (en) 2015-01-29
KR101781255B1 (ko) 2017-09-22
HK1207374A1 (en) 2016-01-29
ES2648228T3 (es) 2017-12-29
CA2874819A1 (en) 2013-12-12
BR112014029851A2 (pt) 2017-06-27
HRP20171724T1 (hr) 2018-01-12
JP5814467B2 (ja) 2015-11-17
RU2014153627A (ru) 2016-08-10
MX2014014803A (es) 2015-02-12
PH12014502721B1 (en) 2015-02-02

Similar Documents

Publication Publication Date Title
HRP20171724T1 (hr) Imidazo[1,2-b]piridazin derivati kao inhibitori kinaze
IL234485A (en) Compounds based on imidazo [2,1 – b] pyridazine
HK1222659A1 (zh) 吡咯並 嘧啶衍生物，它們的製備方法和它們作爲激酶抑制劑的用途
ZA201307839B (en) Pyrazolo[4,3-d] pyrimidines useful as kinase inhibitors
HK1189229A1 (zh) 三環吡咯並衍生物、它們的製備方法和它們作為激酶抑制劑的應用
IL235819A0 (en) Preparation of pyrrolo[b–3,2]pyridines
AP2014007899A0 (en) 2-Amino, 6-phenyl substituted pyrido [2,3-D] pyrimidine derivatives useful as RAF kinase inhibitors
IL243092B (en) New triazolo[d–4,5]pyrimidine histories
LT2812337T (lt) Furo[3,2-b]piridino dariniai, kaip tbk1 ir ikk inhibitoriai
AP2013007045A0 (en) 6-Cyclobutyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivatives their use as PDE9A inhibitors
ZA201405070B (en) 1h-pyrrolo[2,3-b] pyridine derivatives and their use as kinase inhibitors
HK1201830A1 (en) Substituted imidazopyrazines as akt kinase inhibitors akt
SG11201503977PA (en) Azaindole derivatives as jak3 inhibitors
ZA201406323B (en) Triazolo[4,5-d]pyrimidine derivatives
EP2970278A4 (en) Pyrrolo [2,3] PYRIDINE KINASE INHIBITORS CDK9-
HK1206354A1 (en) Pyrrolo[2,3-b]pyrazines as syk inhibitors syk [23-b]
SG11201408816QA (en) 3-(PYRAZOLYL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS
SG10201408059QA (en) 5-oxo-5, 8-dihydropyrido [2, 3-d] pyrimidine derivatives as camkii kinase inhibitors for treating cardiovascular diseases
EP2523552A4 (en) PYRAZOLO- [1,5-A] PYRIMIDINE AS MARK HEMMER
HK1201831A1 (en) Substituted pyrazolopyrimidines as akt kinase inhibitors akt
SG11201500883YA (en) 5-(1H-PYRAZOL-4-YL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS